EYESHOT (EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian Coronary Care Units)

NCT02015624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2597

Last updated 2021-02-03

No results posted yet for this study

Summary

This register will evaluate the use of different antithrombotic therapies, combinations of different drugs routinely used during any stage of hospital admission, with their timing, dosage and mode of administration, in patients with a diagnosis of Acute Coronary Syndrome in the Italian Coronary Care Unit during a study period of three weeks

Conditions

  • Acute Coronary Syndromes

Sponsors & Collaborators

  • Centro Servizi ANMCO S.r.l.

    collaborator UNKNOWN
  • AstraZeneca

    collaborator INDUSTRY
  • Heart Care Foundation

    lead OTHER

Principal Investigators

  • Stefano De Servi, MD · Ospedale Civile - Legnano

  • Leonardo De Luca, MD · European Hospital - Roma

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02015624 on ClinicalTrials.gov